HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John W Barrett Selected Research

Interferon-gamma (Interferon, gamma)

8/2019High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells.
5/2003Role of the serine-threonine kinase PAK-1 in myxoma virus replication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John W Barrett Research Topics

Disease

37Neoplasms (Cancer)
01/2022 - 11/2005
21Squamous Cell Carcinoma of Head and Neck
03/2022 - 01/2012
11Infections
09/2009 - 05/2003
6Head and Neck Neoplasms (Head and Neck Cancer)
10/2021 - 11/2014
3Anaplastic Thyroid Carcinoma
01/2020 - 01/2014
3Carcinogenesis
10/2019 - 04/2014
3Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2017 - 09/2014
3Myxoma (Myxomas)
09/2014 - 02/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 04/2012
2Pain (Aches)
01/2022 - 01/2014
2Oropharyngeal Neoplasms
01/2022 - 11/2020
2Fibrosis (Cirrhosis)
12/2021 - 01/2020
2Carcinoma (Carcinomatosis)
08/2019 - 10/2017
2Vaccinia
09/2014 - 01/2014
2Inflammation (Inflammations)
10/2009 - 12/2005
2Neoplasm Metastasis (Metastasis)
01/2008 - 09/2007
1Chronic Pain
01/2022
1Opioid-Related Disorders (Opiate Addiction)
01/2022
1Thyroid Nodule (Nodule, Thyroid)
01/2021
1Hypoxia (Hypoxemia)
12/2020
1Neutropenia
11/2020
1Deglutition Disorders (Dysphagia)
11/2020
1Ototoxicity
11/2020
1Disease Progression
01/2020
1Idiopathic Pulmonary Fibrosis
01/2020
1Wounds and Injuries (Trauma)
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
01/2015
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2012
1Tonsillar Neoplasms
01/2012

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
10/2021 - 05/2005
6Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2012
5NucleotidesIBA
10/2021 - 01/2019
5Messenger RNA (mRNA)IBA
02/2021 - 10/2017
4DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2012
4RNA (Ribonucleic Acid)IBA
10/2021 - 07/2008
4Phosphotransferases (Kinase)IBA
01/2008 - 05/2003
3CytokinesIBA
12/2021 - 12/2005
3IntegrinsIBA
12/2021 - 10/2009
3Pharmaceutical PreparationsIBA
09/2017 - 11/2014
3Sirolimus (Rapamycin)FDA Link
01/2008 - 02/2007
2MicroRNAs (MicroRNA)IBA
01/2022 - 10/2021
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2021 - 01/2020
2CollagenIBA
12/2021 - 01/2020
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021 - 01/2020
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2020 - 09/2007
2Mechanistic Target of Rapamycin Complex 2IBA
01/2020 - 10/2019
2Phosphatidylinositols (Phosphatidylinositol)IBA
10/2019 - 06/2013
2Interferon-gamma (Interferon, gamma)IBA
08/2019 - 05/2003
2Codon (Codons)IBA
01/2016 - 06/2013
2ErbB Receptors (EGF Receptor)IBA
09/2014 - 04/2012
2Antiviral Agents (Antivirals)IBA
04/2009 - 01/2008
2Interferon Type IIBA
07/2008 - 12/2004
1Morphine (MS Contin)FDA LinkGeneric
01/2022
1Opioid Analgesics (Opioids)IBA
01/2022
1human MIRN421 microRNAIBA
10/2021
1ProteomeIBA
10/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
02/2021
1PlatinumIBA
02/2021
1Circulating Tumor DNAIBA
01/2021
1AlpelisibIBA
10/2020
1ChemokinesIBA
01/2020
1Blocking AntibodiesIBA
01/2020
1GSK3008348IBA
01/2020
1maleic acid (maleate)IBA
01/2020
1Syk KinaseIBA
01/2020
1alvocidib (flavopiridol)IBA
01/2020
1Cisplatin (Platino)FDA LinkGeneric
10/2019
1Viral AntigensIBA
01/2018
1lestaurtinibIBA
01/2018
1Oncogene Proteins (Oncogene Protein)IBA
10/2017
1InterferonsIBA
10/2017
1Adenosine Monophosphate (AMP)IBA
10/2017
1Histocompatibility Antigens Class IIBA
10/2017
1I-antigenIBA
10/2017
1Albendazole (Albenza)FDA Link
09/2017
1Cyclin-Dependent Kinase Inhibitor p16IBA
09/2017
1Histones (Histone)IBA
02/2017
1LDL Receptors (LDL Receptor)IBA
01/2015
1Docetaxel (Taxotere)FDA Link
11/2014
1Gefitinib (Iressa)FDA Link
11/2014
1bosutinibIBA
11/2014
1AfatinibIBA
11/2014
12- (1- (7- methyl- 2- morpholin- 4- yl- 4- oxo- 4H- pyrido(1,2- a)pyrimidin- 9- yl)ethylamino)benzoic acidIBA
11/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014
1Fibronectins (Fibronectin)IBA
04/2014
1Notch ReceptorsIBA
08/2012
1Tyrosine Kinase InhibitorsIBA
06/2010
1GenisteinIBA
06/2010
1Virulence Factors (Pathogenicity Factors)IBA
09/2009
1Tyrosine (L-Tyrosine)FDA Link
04/2009
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2009

Therapy/Procedure

13Therapeutics
01/2022 - 09/2007
3Radiotherapy
01/2022 - 04/2012
3Drug Therapy (Chemotherapy)
01/2022 - 01/2020
3Oncolytic Virotherapy
11/2007 - 02/2007
1Gastrostomy
11/2020
1Neoadjuvant Therapy
10/2019
1Immunotherapy
01/2018
1Precision Medicine
01/2014